These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 15652588)
1. NOTCH1 pathway: a molecular target in T-cell cancers? Holowiecki J Lancet; 2005 Jan 15-21; 365(9455):197-9. PubMed ID: 15652588 [No Abstract] [Full Text] [Related]
2. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Weng AP; Ferrando AA; Lee W; Morris JP; Silverman LB; Sanchez-Irizarry C; Blacklow SC; Look AT; Aster JC Science; 2004 Oct; 306(5694):269-71. PubMed ID: 15472075 [TBL] [Abstract][Full Text] [Related]
3. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Pear WS; Aster JC Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998 [TBL] [Abstract][Full Text] [Related]
4. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Lee SY; Kumano K; Masuda S; Hangaishi A; Takita J; Nakazaki K; Kurokawa M; Hayashi Y; Ogawa S; Chiba S Leukemia; 2005 Oct; 19(10):1841-3. PubMed ID: 16079893 [No Abstract] [Full Text] [Related]
5. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Hales EC; Taub JW; Matherly LH Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475 [TBL] [Abstract][Full Text] [Related]
6. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065 [TBL] [Abstract][Full Text] [Related]
7. Molecular pathways in T-cell acute lympho-blastic leukemia: ramifications for therapy. Look AT Clin Adv Hematol Oncol; 2004 Dec; 2(12):779-80. PubMed ID: 16166953 [No Abstract] [Full Text] [Related]
8. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257 [TBL] [Abstract][Full Text] [Related]
9. Kick it up a Notch: NOTCH1 activation in T-ALL. Gridley T Cancer Cell; 2004 Nov; 6(5):431-2. PubMed ID: 15542425 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Notch function in presomitic mesoderm suggests a gamma-secretase-independent role for presenilins in somite differentiation. Huppert SS; Ilagan MX; De Strooper B; Kopan R Dev Cell; 2005 May; 8(5):677-88. PubMed ID: 15866159 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture. Chiaramonte R; Calzavara E; Balordi F; Sabbadini M; Capello D; Gaidano G; Serra A; Comi P; Sherbet GV J Cell Biochem; 2003 Feb; 88(3):569-77. PubMed ID: 12532332 [TBL] [Abstract][Full Text] [Related]
12. GSIs described as most important finding in cancer-targeting research. Expert Rev Anticancer Ther; 2002 Dec; 2(6):617-8. PubMed ID: 12503199 [No Abstract] [Full Text] [Related]
13. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Zhang Z; Nadeau P; Song W; Donoviel D; Yuan M; Bernstein A; Yankner BA Nat Cell Biol; 2000 Jul; 2(7):463-5. PubMed ID: 10878814 [No Abstract] [Full Text] [Related]
14. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224 [TBL] [Abstract][Full Text] [Related]
15. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Minter LM; Turley DM; Das P; Shin HM; Joshi I; Lawlor RG; Cho OH; Palaga T; Gottipati S; Telfer JC; Kostura L; Fauq AH; Simpson K; Such KA; Miele L; Golde TE; Miller SD; Osborne BA Nat Immunol; 2005 Jul; 6(7):680-8. PubMed ID: 15991363 [TBL] [Abstract][Full Text] [Related]
16. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells. Kogoshi H; Sato T; Koyama T; Nara N; Tohda S Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552 [TBL] [Abstract][Full Text] [Related]